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Abstract
Background: The accurate diagnosis of Eustachian tube (ET) dysfunction can be very difficult. Our aim is to
determine whether a 678 Hz probe tone is a more accurate indicator of Patulous ET (PET) than the 226 Hz probe
tone when used in compliance over time (COT) testing.
Methods: Twenty subjects (11 normal ET ears and 7 PET ears) were individually seated in an examination room and
connected to a GSI TympStar Middle Ear Analyzer. The order of probe tone frequency (678 or 226 Hz) was
randomized. Baseline “testing” COT recordings for each ear undergoing testing were completed. Subjects were
instructed to occlude their contralateral nostril and to breathe forcefully in and out through their ipsilateral nostril
until the test had run to completion. This process was repeated with the probe tone that had not been previously
run. For the control group, each subject had one random ear tested. For the experimental group, only the affected
ear(s) was tested. Wilcoxon rank rum tests were performed to determine statistical significance.
Results: The baseline COT measurements for the control group and PET group were similar, 0.86 mL (SD = 0.34)
and 0.74 (SD = 0.33) respectively. Comparing the 226 Hz tone between groups revealed that PET patients had a
median COT difference 0.19 mL higher than healthy ET patients, and for the 678 Hz tone, PET patients had a
median COT difference of 0.57 mL higher than healthy ET patients. Both were deemed to be statistically significant
(p = 0.002, p = 0.004 respectively). The was a statistically significant median COT difference between the 678 Hz and
226 Hz of 0.61 mL (p = 0.034) for the PET group, while the same comparison for the control group of 0.05 mL was
not significant (p = 0.262), suggesting that the 678 Hz tone yields a larger response for PET than the 226 Hz tone,
and no difference for the control group, thus making it less prone to artifact noise interference.
Conclusion: The 678 Hz probe tone is a more reliable indicator of ET patency, and should be preferably used over
the 226 Hz tone for future COT testing.
Background
The Eustachian tube (ET) is a narrow, epithelial-lined
osseocartilaginous tube that connects the middle ear
cavity to the nasopharynx [1, 2]. It functions to maintain
middle ear health and to facilitate sound transmission
from the tympanic membrane (TM) to the inner ear [3].
The ET accomplishes this by fulfilling three major
physiologic roles, which include drainage of middle ear
secretions, prevention of nasopharyngeal reflux and,
most importantly, pressure equalization across the TM
[4, 5]. The proper functioning of the ET greatly depends
on the regular intermittent opening and closing of the
tube. At rest, the ET is passively collapsed; however, the
ET can be actively opened under the control of paratubal
muscles during such activities as swallowing, yawning
and chewing [2, 6]. Any aberration in opening and
closing is considered ET dysfunction (ETD) and can be
further classified as either obstructive or patulous
dysfunction [3, 4, 7].
Obstructive ETD is inadequate tubal opening caused
by either paratubal muscular failure or obstruction of
the ET by intrinsic changes. Failure of the ET to open
typically results in patients complaining of aural fullness,
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periodic ‘popping’ sounds, muffled hearing and tinnitus
[8]. Left untreated, patients with obstructive ETD can
develop cholesteatoma, perforation, middle ear effusions
and conductive hearing loss [4, 9].
A patulous Eustachian tube (PET) is a far less common
type of ETD where the ET remains abnormally open
intermittently or permanently, allowing for excessive
communication between the middle ear and nasopharynx
[10]. Reported potential risk factors for PET include
sudden and severe weight loss, pregnancy, radiation ther-
apy and congenital ET defects; nonetheless, many patients
do not have any predisposing factors [10–16].
The most typical symptoms of PET include autophony
(hearing one’s own voice) and aerophony (hearing one’s
own breathing), and often aural fullness [17]. Vertigo,
tinnitus and conductive hearing loss have been de-
scribed, but in our experience, are less common [18]. In
severe cases, symptoms are so distressing that patients
progress to develop psychiatric sequelae, such as suicidal
ideation and major depressive episodes [15]. Some
symptoms, such as autophony can overlap with other
disorders, such as superior canal dehiscence. Classically,
autophony and aerophony are made worse with standing
and exercise, and are improved by lying down [19].
However, symptoms can be intermittent and not present
when the patient is seen in clinic. The definitive diagno-
sis of PET is made on direct otoscopic observation of
the tympanic membrane moving synchronously with
respiration: this is the result of transmission of nasopha-
ryngeal air pressures directly to the middle ear cavity
(MEC) through the patent ET. The movement of the
tympanic membrane can be exacerbated by having the
subject sit upright and take deep breaths while occluding
one nostril, to accentuate nasopharyngeal pressure
changes [19].
Despite several different methods being employed over
the years, there is no universally accepted protocol for
the evaluation of a patent ET [10]. Nasal endoscopy is
frequently used to examine the pharyngeal opening of
the ET; however, due to a narrow tubular lumen, the
opening being eccentric to the line of visualization, the
valve area being mostly hidden, and the presence of
secretions, diagnostic visualization of the ET is usually
very difficult [20].
Various researchers have suggested the use of acoustic
immittance and standard tympanometry to indirectly
observe the respiratory-synchronous movements of the
tympanic membrane in the presence of PET [4, 21, 22].
During an acoustic immitance measurement, the tym-
panometer generates a pure tone of a specific frequency
that is delivered into the ear canal via its probe compo-
nent., and the reflected sound measured. This is a meas-
ure of the acoustic impedance and admittance. The
typical, tympanometric probe tone is 226 Hz. Acoustic
admittance (the reciprocal of acoustic impedance) is a
reliable surrogate for compliance when the tone is of a
relatively low frequency.
A tympanometer can graph the compliance over time
(COT) of the tympanic membrane (sometimes called long
time-base tympanometry, and often found on the reflex
decay testing function in commercial tympanometers),
and this is helpful in the evaluation ET function. During
the test, the patient is asked to perform various breathing
exercises (e.g. ipsilateral nostril breathing or sniffing) to
see the effect on the tympanic membrane’s COT.
Exaggerated changes in tympanic membrane compliance
synchronous with inhalation and exhalation are indicative
of a PET [10].
Compliance over time using 226 Hz pure tones has
been shown to identify PET via respiratory-synchronous
middle ear compliance with occlusion of the contralat-
eral nostril and forced ipsilateral nostril breathing [10,
22–24]. Nonetheless, we have found in our ET practice
that alterations in COT measurements using a 678 Hz
pure tone is more powerfully predictive of PET than any
other tone used before. This was observed when using
COT testing with the 226 Hz frequency in the
Eustachian Tube clinic; anecdotally, the false-positive
rate was too high and the signals too small to reliably
interpret with the 226 Hz tone.
The aim of this study was to evaluate results of COT
testing in presumed closed and patulous Eustachian
tubes, and to compare the 226 Hz and 678 Hz probe
tones to determine if the latter provides a clearer distinc-
tion between patulous ET and closed ET, which has not
been previously described. We hypothesize, based on
our observations, that the PET group will produce
stronger, clearer, and more identifiable patterns of COT
using a 678 Hz pure tone when compared with the
226 Hz frequency, while the closed ET group will yield
similar results for each respective tone.
Methods
Subject selection
Ethics approval was obtained from our institutional
research ethics board. Through the Eustachian Tube
Clinic at our institution, subjects were identified as
having suspected PET and asked to participate in this
study. These subjects experienced one or more of the
symptoms of autophony, aerophony, and/or aural full-
ness. All PET subjects were examined with otoscopy and
microscopy to confirm that there was no obstruction in
the ear canal, no current visible ear disease, and that the
TM was moving with respiration prior to testing. Any
subjects not meeting these criteria were excluded from
the PET group (experimental group). These were our
confirmed PET subjects.
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To obtain our healthy ET group (control group),
subjects with no prior history of ear disease, no previous
ear surgery, and no current ET dysfunction were
recruited. All healthy subjects were examined with
otoscopy to confirm that there was no obstruction in the
ear canal, no current visible ear disease, and that the TM
was not moving with respiration prior to testing. Any
ears not meeting these criteria were excluded from the
control group.
Data collection
Data was collected prospectively. Subjects were seated
upright in an examination room and connected to a GSI
TympStar Middle Ear Analyzer (Grason-Stadler, MN,
USA). A typical tympanogram was completed on each
subject. The machine was then set to the acoustic reflex
decay test protocol (allowing for a 15-s recording/10 s
analysis window) and either the 226 Hz probe tone or
the 678 Hz probe tone was selected. The acoustic reflex
stimulus setting was set to the CONTRA option, but the
contralateral earphone was not placed in the subject’s
opposite ear; the stimulus level was also set to 35 dB, i.e.
there was no acoustic stimulus applied that could cause
a stapedial reflex. The order of probe tone frequency
(678 or 226 Hz) was randomized. Baseline “testing”
COT recordings for each ear undergoing testing were
completed. This measured the middle ear admittance
over the 15 s window in the absence of any acoustic
stimuli or subject maneuvering. As such, this was the
admittance over time with the middle ear “at rest.” COT
testing for PET was then completed. Just prior to initiat-
ing the test, each subject was instructed to occlude their
contralateral nostril. The testing protocol was initiated,
and each subject was instructed breathe forcefully in and
out through their ipsilateral nostril until the test had run
to completion, which increases nasopharyngeal pressure
changes, and therefore emphasize the effects of a PET.
This process was repeated with the probe tone that had
not been previously run. For the control group, each
subject had one random ear tested. For the experimental
group, only the affected ear(s) was tested. All results
were retrieved from the TympStar printer upon comple-
tion of each test run.
Statistical analysis
A descriptive analysis was performed on patient demo-
graphics. These are represented by averages, range, and
standard deviation. For statistical analysis, COT values at
both 226 Hz and 678 Hz were compared between
healthy and PET subjects, as well as within each subject
group. A case control design was implemented. With
PET patients representing cases and healthy ET patients
representing controls. Wilcoxon rank sum tests were
performed to determine statistical significance. All
analysis was performed with R version 3.3.1 (“Bug in
Your Hair”). Effect sizes are presented as medians and
approximate 95% confidence intervals. Non-parametric
testing was utilized as sample sizes in our study were
insufficient to rely on assumptions of asymptomatic
normality for the purposes of hypothesis testing. A p
value < 0.05 was considered statistically significant (95%
confidence interval.)
Study population
The control group consisted of eight males and three
females with a mean age of 28.7 years (range: 24 years to
46 years; SD = 5.8 years). Of this group, three members
described having symptoms of tinnitus intermittently.
None had hearing loss or experienced autophony.
The experimental group consisted of four males and
three females with a mean age of 35.7 years (range:
23 years to 50 years; SD = 12.3 years). Of these patients,
two had a sensorineural hearing loss and one had a hear-
ing loss that was conductive in nature. Three patients
from the experimental group could volitionally open
their ET, and tests were performed when they were sure
their ETs were open, which was confirmed by observa-
tion of movement of the TM with respiration. Four
patients reported symptoms of autophony. None
reported tinnitus. Data are reported as means and
standard deviations (SD).
Results
The study included a total of 18 patients (18 ears) who
underwent COT testing, demographics are in Table 1.
Both the average and range of magnitude of MEC were
recorded for each group.
In the control group (11 ears), the resting tympanogram
compliance average was 0.86 mL (SD = 0.34 mL), which is
comparable to that of the experimental group (0.74 mL,
SD = 0.33 mL), however two PET ears were missed for this
stage of testing. The average change in middle ear
compliance (COT) was 0.07 mL (SD = 0.05 mL) for the
226 Hz frequency, and 0.12 mL (SD = 0.12 mL) for the
678 Hz frequency (Table 2). Figure 1 shows COT tracings
for a healthy ET subject at the 226 Hz and 678 Hz fre-
quencies. For the PET group (7 ears), the average middle
ear compliance change was 0.26 mL (SD = 0.08 mL)
and 0.69 mL (SD = 0.35 mL) for the 226 Hz and
678 Hz frequencies, respectively (Table 2). Figure 2
shows COT tracings for a PET subject at the 226 Hz
and 678 Hz frequencies.
Table 1 Demographics of study population
Mean Age, yrs (range) Male Female
Healthy ET 28.63 (24–46) 8 3
PET 35.71 (22–50) 4 3
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For comparison of results between groups, the difference
between median COT at each frequency was evaluated
(Table 3). It was found that for the 226 Hz frequency, the
experimental group had an average COT of 0.19 mL more
than the control group (0.26 mL vs 0.07 mL) and this was
statistically significant (p = 0.002, Fig. 3). The median COT
difference between groups at the 678 Hz frequency the
difference was found to be 0.57 mL (0.69 mL vs. 0.12 mL)
and this statistically significant (p = 0.004, Fig. 4). The differ-
ence between COT at 678 Hz and 226 Hz for the control
group was 0.05 mL, while for the experimental group, this
difference was 0.61 mL. The later was found to be statisti-
cally significant (p = 0.034) while there was no significant
relationship seen in the former (p = 0.262).
Discussion
Evaluation of ET function via tympanometry has been
used for many years, but it certainly has its challenges.
Primarily, the 226 Hz tone provides only limited reliabil-
ity for distinguishing between healthy and diseased ET states. This study investigated the compliance over time
(COT) of patulous ET and healthy ET patients when
subjected to 226 Hz and 678 Hz tones, with the goal of
determining if the latter yielded a clearer distinction
between the healthy and disease ET states. Although
based on our statistical analysis, both the 226 Hz and
678 Hz frequencies yielded results that indicate they can
distinguish between healthy ET and PET states, in com-
parison with the former, the latter method shows a very
strong response for PET subjects, and in some cases, the
response was higher than the limits of the TympStar
instrument. This limitation is due to the fact the we have
independently adapted this machine to run the tests we
have set up. As such, the TympStar as commercially
Fig.2 a and b Tympanogram tracings of a PET subject during
testing with 226 Hz (a) and 678 Hz (b) probe tone. The y-axis
represents middle ear compliance (MEC), measured in mL or mmho.
The x-axis represents time, measured in seconds (s). A detailed
outline of the procedure is described in the “Data Collection” section
of this manuscript. Based on an algorithm used by the creators of
the TympStar, the maximum MEC during testing is calculated. The
tracings indicate movement of the TM with each respiration
Table 3 Wilcoxon Rank-Sum test for COT difference between
healthy ET and PET at 226 Hz and 678 Hz probe tones
Median
Difference
95 CI p
PET 226 Hz vs. healthy
ET 226 Hz
0.19 (0.09 to 0.28) 0.002
PET 678 Hz vs. healthy
ET 678 Hz
0.57 (0.25 to 0.93) 0.004
Healthy 678 Hz vs
Healthy 226 Hz
0.05 (−0.02 to 0.09) 0.262
PET 678 Hz vs PET
226 Hz
0.61 (0.01 to 0.79) 0.034
Fig. 1 a and b Tympanogram tracings of a healthy ET subject
during testing with 226 Hz (a) and 678 Hz (b) probe tone. The y-axis
represents middle ear compliance (MEC), measured in mL or mmho.
The x-axis represents time, measured in seconds (s). A detailed
outline of the procedure is described in the “Data Collection” section
of this manuscript. Based on an algorithm used by the creators of
the TympStar, the maximum MEC during testing is calculated. The
tracings indicate movement of the TM with each respiration
Table 2 Comparison of healthy ET and PET COT following
testing of 226 Hz and 678 Hz probe tones
226 Hz 678 Hz
Average COT (mL) SD (mL) Average COT (mL) SD (mL)
Healthy ET 0.07 0.05 0.12 0.12
PET 0.26 0.08 0.69 0.35
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configured is not the ideal instrument for measuring
positive PET responses. Nonetheless, the upper limit of
recording was 0.99 mmho and any response that
exceeded this value were recorded as the maximum (0.99
mmho). If an instrument with the capability of reading up
to 2.0 mmho or even 3.0 mmho was available, a more
exact measurement of MEC would be possible. While the
226 Hz frequency does appear to show a distinction
between healthy ET and PET states, the response is much
lower than the 678 Hz probe tone, suggesting that the
former could yield false positive results due to random
noise.
One interesting aspect of our analysis was the com-
parison of probe tones within each subject group. There
was no statistically significant difference between the
226 Hz and 678 Hz frequencies COT responses for the
control group, which would support the notion that both
are equally as effective at avoiding a false positive non-
healthy ET state. However, comparing the same two
tones for the experimental group, we found that the
678 Hz frequency had a significantly higher response
than the 226 Hz frequency, offering further support that
the former is the ideal frequency for this methodology of
testing.
When evaluating the readouts from the instrument, it
appeared that there was an apparent discrepancy
between the displayed reading and the paper tracing
produced. According to the manufacturer of the
TympStar machine, a complicated and proprietary
algorithm – which is beyond the scope of this paper –
is used to produce the peak value reading, and little
weight should be given to the tracings per se, rather
Fig. 3 Comparison of middle ear compliance (MEC) between healthy ET and PET subjects at the 226 Hz probe tone frequency. The y-axis
represents MEC, measured in mmho. The x-axis displays each respective group, with healthy ET represented by the blue bar, and PET represented
by the red bar. It was found that the PET group had significantly higher MEC than the healthy ET group during testing with forced
respiration (p = 0.02)
Fig. 4 Comparison of middle ear compliance (MEC) between healthy ET and PET subjects at the 678 Hz probe tone frequency. The y-axis
represents MEC, measured in mmho. The x-axis displays each respective group, with healthy ET represented by the blue bar, and PET represented
by the red bar. It was found that the PET group had significantly higher MEC than the healthy ET group during testing with forced
respiration (p = 0.04)
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the actual numbers reported on screen are more
accurate.
It is important to acknowledge one of the limitations
to our study: the sample size. However, given that many
subjects with intermittent PET displayed no eardrum
movements at the time of testing, or they stopped
between microscopic examination and going to the test-
ing area, it is difficult to obtain a large population of
gold standard subjects. Thus, a longer study period may
afford the necessary amount of time to discover a larger
group of subjects.
Conclusion
To our knowledge, this is the first study to describe the
678 Hz probe tone in evaluation of middle ear immi-
tance and compliance over time. Based on the evidence
presented here, this suggests that this tone is a more
reliable distinguisher between healthy ET and PET states
than the previously accepted frequency. A study aimed at
a larger population would be ideal for further evaluation.
Additionally, using an instrument with the ability to rec-
ord larger amplitude responses would allow more precise
and accurate measurements of PET responses.
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